Alzheimer's Association criticises Nymox:
This article was originally published in Clinica
Executive Summary
The US Alzheimer's Association has recommended against using Nymox' AD7C test. The association says there is no published data on the test's ability to rule out Alzheimer's disease and describes Nymox' marketing as aggressive and objectionable. The test detects neural thread proteins, which the Alzheimer's Association says is also found in people with brain tumours and stoke victims. Nymox promotes the test directly on the World Wide Web.